Co-trimoxazole prescription at the outpatient service of a secondary health facility in Ibadan, Nigeria

Journal of Medical Sciences

Volumn 6, Issue 3, 2006, Pages 416-419

  Fehintola, F A ^a   Ganiyu, A A ^b   Akinmusure, O ^a   Oduntan, H A ^c   Adeyinka, J O ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b Jericho General Hospital   (Nigeria)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Chemotherapy; Cotrimoxazole; Infections; Malaria; Plasmodium falciparum; Pneumocystis carinii

Indexed keywords

ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTIPYRETIC AGENT; ANTIULCER AGENT; ANTIVIRUS AGENT; ARTESUNATE; CHLOROQUINE; COTRIMOXAZOLE; FANSIDAR; INOTROPIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; PSYCHOTROPIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGE; AGED; AMEBIASIS; ARTICLE; CHILD; CONTROLLED STUDY; DRUG MISUSE; DRUG UTILIZATION; FEMALE; GENDER; GOVERNMENT; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; INJURY; LACERATION; MAJOR CLINICAL STUDY; MALARIA; MALE; MASTITIS; MEDICAL DOCUMENTATION; NIGERIA; PAIN; PEPTIC ULCER; PRESCRIPTION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SCABIES; SCHISTOSOMIASIS; SKIN BRUISING; URINARY TRACT INFECTION; UTERUS MYOMA;

EID: 33745736814     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2006.416.419     Document Type: Article

References (12)

1. Akingbade, S.A. and S.A. Odedokun, 1995. Survey of Bactrim® Clinical Experience Among Nigerian Infectious Disease Specialists and General Practitioners. Niger. Med. Pract., 30:69-71
2. Anonymous, 1994. Epi-info version 6. A word processing data base and statistics program for public health on IBM-convertible microcomputers. Atlanta, Georgia: Centers for Disease Control and Prevention and Geneva: WHO.
3. Bloland, P.B., S.C. Redd, P. Kazembe, R. Tembenu, J.J. Wirima and C.C. Campbell, 1991. Cotrimoxazole for childhood febrile illness in malaria endemic regions. Lancet, 337:518-520.
4. Campbell, H., P. Byass, I.M. Forgie, K.L. O'Neill, N. Lloyd-Evans and B.M. Greenwood, 1998. Trial of co-trimoxazole versus procaine penicillin with amoxicillin in treatment of community-acquired pneumonia in young Gambian children. Lancet, 2: 1182-84.
5. Fasan, P.O., 1971. Trimethoprim plus sulphamethoxazole compared with chloroquine in the treatment and suppression of malaria in African school children. Ann. Trop. Med. Parasitol., 65: 117-121.
6. Fehintola, F.A., A.A. Adedeji and A. Sowunmi, 2002. Comparative efficacy of chloroquine and cotrimoxazole in the treatment of acute uncomplicated falciparum malaria in Nigerian children. Cent. Aft. J. Med., 48: 101-105.
7. Fehintola, F.A., A.A. Adedeji, E. Tambo, B.A. Fateye, T.C. Happi and A. Sowunmi, 2004. Cotrimoxazole in the treatment of falciparum malaria in Nigerian children: A controlled clinical trial. Clin. Drug Invest., 24: 149-155.
8. Gleckman, R., S. Alvarez and D.W. Joubert, 1979. Drug therapy reviews: Trimethoprimsulfamethoxazole. Am. J. Hosp. Pharm., 36:693-906
9. Milhous, W.K., N.F. Weatherly, J.H. Bowdre and R. Desjardins, 1985. In vitro activities of and mechanisms of resistance to antifolate antimalarial drugs. Antimicrob. Agents Chemother., 27: 525-530.
10. Spencer, H.C., 1985. Drug-resistant malaria: Changing patterns mean difficult decisions. Trans. R. Soc. Trop. Meal. Hyg., 79: 748-758.
11. Wernsdorfer, W. H., 1991. The development and spread of resistant malaria. Parasitol. Today, 7: 297-303.
12. White, N., 1999. Antimalarial drug resistance and combination chemotherapy. Phil. Trans. R. Soc. Lond. B., 354: 739-749.